Browsing by Subject "Safety"
Now showing items 1-1 of 1
-
(Elsevier, 2015)Background New therapeutic options are needed for patients with psoriasis. Tofacitinib, an oral Janus kinase inhibitor, is being investigated as a treatment for moderate-to-severe chronic plaque psoriasis. In this study, ...